基于 DNA 超分子水凝胶的保护性 NK 细胞储库用于增强三阴性乳腺癌治疗
Protective NK Cell Reservoir Based on DNA Supramolecular Hydrogel for Enhanced Triple-Negative Breast Cancer Therapy.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Prognostic Significance of CD8 T-cell Spatial Biomarkers in ER+ and ER- Breast Cancer.
Prognostic Significance of CD8 T-cell Spatial Biomarkers in ER+ and ER- Breast Cancer.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
TIL(肿瘤浸润淋巴细胞)已被证明可预测三阴性乳腺癌(TNBC)预后,但在其他亚型,尤其雌激素受体(ER)阳性癌症(占乳腺癌70%–80%)中很少评估,原因是TIL数量较低。
然而,低丰度TIL的空间邻近性与乳腺癌预后的关系尚未研究。本研究利用多重免疫荧光染色图像,根据细胞角蛋白(Ck)、CD8和FoxP3表达识别细胞类型。通过计算上皮细胞和免疫细胞间的距离可视形态测量,我们构建了邻近度和一致性两项新指标,以描述Ck⁺肿瘤细胞与CD8⁺ T细胞的空间关系。采用log-rank检验,将邻近度和一致性的预后意义与淋巴细胞计数进行比较。ER阳性和ER阴性乳腺癌中,CD8⁺细胞邻近度和一致性低均与较差的无复发生存期(RFS)相关。在ER阴性乳腺癌中,邻近度的RFS风险比最高(HR 1.84;95% CI 1.18–2.87)。在ER阳性患者中,邻近度和一致性的RFS风险比分别为2.04(95% CI 1.39–2.98)和1.82(95% CI 1.23–2.69)。这些关联强于淋巴细胞计数的关联(HR 1.35;95% CI 0.92–1.98;log-rank P=0.13)。基于免疫荧光的空间指标还与已建立的TIL指标及基于RNA表达的肿瘤适应性免疫反应指标相关。邻近度在ER阳性乳腺癌中的预后意义提示,空间参数可能识别可从免疫治疗中获益的个体;多达75%的乳腺癌表现出提示免疫易感性的T细胞邻近特征。
Tumor Infiltrating Lymphocytes (TILs) have been shown to be prognostic in Triple-Negative Breast Cancer (TNBC), but are rarely considered in other subtypes, particularly estrogen receptor (ER) positive cancers (70-80% of breast cancers), due to lower TIL counts.
However, the spatial proximity of lower abundance TILs has not been evaluated in relation to breast cancer prognosis. In this study, multiplex immunofluorescent-stained images were used to identify cell types based on cytokeratin (Ck), CD8, and FoxP3 expression. Using distance-based visual morphometry between epithelial and immune cells, we computed new metrics, proximity and consistency , which capture spatial relationships between Ck+ tumor cells and CD8+ T-cells. Prognostic significance of proximity and consistency were compared to lymphocyte counts using log-rank tests. Worse relapse-free survival (RFS) was observed for both ER+ and ER- breast cancers with low proximity and consistency of CD8+ cells. Among ER negative breast cancers, proximity had the highest RFS hazard ratio (HR 1.
84, 95% CI [1. 18,2. 87]). Among ER positive participants, RFS hazard ratios for proximity and consistency were 2. 04 (95% CI [1. 39, 2. 98]) and 1. 82 (95% CI [1. 23, 2. 69]) respectively. These associations were stronger than those observed for lymphocyte count (HR 1. 35, 95% CI [0. 92,1. 98], log-rank p-value = 0. 13).
These IF-derived spatial metrics were also associated with established TILs metrics and RNA-based expression-based measures of tumor adaptive immune response. The prognostic significance of proximity in ER+ breast cancer implies that spatial parameters may identify individuals who would benefit from immune therapy; up to 75% of breast cancers experience T-cell proximity suggestive of immune susceptibility.
MEMBER ACCOUNT
登录成功会直接打开下一页。